Nov 8, 2017
OPKO Health Reports 2017 Third Quarter Highlights and Financial Results
Nov 7, 2017
OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform
Nov 3, 2017
OPKO Health to Announce 2017 Third Quarter Financial Results on November 8, 2017
Oct 26, 2017
OPKO Health Licensee TESARO Announces FDA Approval of VARUBI® IV for Delayed Nausea and Vomiting Associated with Chemotherapy
Email Alert Subscription
Step 1 of 3: Select Options
You may automatically receive OPKO Health, Inc. financial information by email. Please enter your preferences for email notifications below and click "Continue"
to enter your contact information on the next page.
If you have already signed up and would like to review your subscription, click here.